Anesthesia for Pediatric Patients: Developmental Considerations and Safe Protocols

By Dr. Zubair Khalid, DVM, MS, PhD · 2026-08-11

Key Takeaways

• Pediatric patients exhibit immature hepatic cytochrome P450 activity and renal glomerular filtration, leading to prolonged drug clearance and increased risk of cumulative effects, necessitating dose reduction and careful titration.
• Higher total body water and lower fat/muscle mass in pediatric patients alter the volume of distribution for lipophilic agents, delaying peak effect and prolonging recovery, thus favoring continuous infusions over repeated boluses.
• The immature cardiovascular system relies heavily on heart rate for cardiac output, making bradycardia a critical threat to perfusion that demands immediate intervention due to reduced myocardial contractile mass and compliance.
• Preclinical evidence suggests anesthetic neurotoxicity in developing brains, warranting avoidance of unnecessary or prolonged anesthetic exposure and utilization of multimodal analgesic techniques to minimize systemic anesthetic requirements.
• Hypothermia is a primary morbidity risk due to immature thermoregulation and a high surface area to mass ratio, requiring active warming measures to commence before anesthetic induction.
• Fasting periods must be species-specific and shorter than for adults to prevent hypoglycemia and dehydration, with blood glucose monitoring recommended for neonates and young pediatric patients.

Pediatric anesthesia in small animal practice demands a working knowledge of developmental physiology, pharmacology, and risk stratification that differs materially from adult patient care. This article addresses the practicing veterinarian who anesthetizes puppies and kittens for routine neutering, fracture repair, or diagnostic imaging, and who needs a framework for anticipating complications before they arise. The content covers the physiological and pharmacological foundations of pediatric anesthesia, fasting and preparation protocols, monitoring standards, and recovery considerations, with attention to the evidence base where it exists and explicit acknowledgment where it does not.

The clinical question at the center of this reference is straightforward: how does the immature patient differ from the adult, and how should those differences change anesthetic planning and execution? The answer draws on comparative developmental biology, pharmacokinetic principles, and consensus guidance from professional bodies such as the AAHA anesthesia and monitoring guidelines for dogs and cats. Where the veterinary literature is thin, relevant human pediatric anesthesia research offers useful direction, particularly regarding neurodevelopmental safety and stress response modulation.

At a Glance

Developmental Physiology and Pharmacology

The pediatric patient is not a small adult. Organ system immaturity alters every phase of anesthetic drug handling, from absorption to elimination, and these differences are most pronounced in the neonatal period. Hepatic microsomal enzyme activity, particularly the cytochrome P450 system, is substantially reduced at birth and matures over the first several weeks of life. Renal glomerular filtration and tubular secretion follow a similar trajectory, reaching adult-equivalent function only after approximately two months in puppies and kittens. The practical consequence is that drug clearance is slower, elimination half-lives are longer, and repeated dosing produces higher plasma concentrations than the same regimen would achieve in an adult.

Body composition compounds these pharmacokinetic differences. Neonates have a higher proportion of total body water and a lower proportion of body fat and skeletal muscle than juveniles or adults. Lipophilic anesthetic agents distribute into a relatively larger volume, which delays peak effect and prolongs recovery. Protein binding is also reduced in neonates because of lower serum albumin concentrations, increasing the free fraction of highly protein-bound drugs and potentiating their effects. These factors together argue for dose reduction, careful titration to effect, and avoidance of repeated bolus dosing in favor of continuous infusion where feasible.

The cardiovascular system of the neonate is characterized by a relatively fixed stroke volume and a heart rate that is the primary determinant of cardiac output. The myocardium has less contractile mass and reduced compliance compared with the adult heart, making it more sensitive to the negative inotropic effects of inhalant anesthetics. Bradycardia in a pediatric patient therefore represents a more serious threat to perfusion than in an adult, and it demands immediate intervention. The immature autonomic nervous system also limits compensatory responses to vasodilation and hypovolemia.

Neurodevelopmental Safety

Concern about anesthetic effects on the developing brain has shaped pediatric anesthesia practice in both human and veterinary medicine. Preclinical studies in rodents and nonhuman primates have demonstrated that exposure to commonly used anesthetic agents during critical periods of synaptogenesis can trigger neurodegeneration, and the FDA's review of anesthetic agents in neonates and young children summarized these findings and outlined regulatory steps to assess human risk. Subsequent work using human neurons differentiated from embryonic stem cells showed that ketamine induces dose- and time-dependent cell death through a mitochondrial apoptosis pathway involving reactive oxygen species, as reported in a laboratory study of ketamine toxicity in human neurons.

Translation of these findings to clinical practice remains uncertain. A systematic review from the American Pediatric Surgical Association concluded that a single exposure to general anesthesia does not appear to produce detectable neurodevelopmental deficits in children when assessed with currently available tools, though the authors noted limitations in study design and follow-up duration, as summarized in the APSA systematic review on early anesthesia and neurodevelopment. The veterinary literature offers no equivalent prospective data. The prudent clinical stance is to avoid unnecessary or prolonged anesthetic exposure in young patients, to use the lowest effective doses of anesthetic agents, and to incorporate regional or locoregional techniques where they can reduce systemic anesthetic requirements. This approach aligns with the multimodal analgesic principles endorsed in the WSAVA global pain management guidelines.

Stress Response and Analgesia

The neuroendocrine stress response to surgery is exaggerated in infants and young children compared with older patients, and blunting that response is associated with improved perioperative outcomes. In human pediatric cardiac surgery, continuous spinal anesthesia added to high-dose intravenous opioid technique significantly reduced plasma catecholamine concentrations compared with opioids alone, as demonstrated in a randomized trial of spinal anesthesia in pediatric open heart surgery. This finding supports the principle that neuraxial and regional techniques have value beyond intraoperative analgesia: they attenuate the metabolic and hormonal consequences of surgical trauma.

For veterinary pediatric patients, the same logic applies. Regional blocks, local anesthetic infiltration, and opioid-sparing analgesic plans reduce the requirement for systemic anesthetics and provide smoother recoveries. The AAHA anesthesia and monitoring guidelines for dogs and cats emphasize preemptive multimodal analgesia as a component of standard anesthetic care, and this is particularly relevant in pediatric patients where the margin between effective and excessive systemic drug dosing is narrow.

Fasting and Metabolic Preparation

Fasting protocols for pediatric patients differ from adult protocols because of the higher risk of hypoglycemia and dehydration. Prolonged fasting depletes the limited hepatic glycogen stores of neonates and young puppies and kittens, and it increases the likelihood of hypotension during anesthesia. Published guidelines from the AAHA recommend shorter fasting intervals for pediatric patients than for adults, with food withheld for a limited period and access to water maintained until shortly before premedication. The exact intervals should be confirmed against the current AAHA anesthesia and monitoring guidelines for dogs and cats and adapted to the individual patient's age, health status, and procedure.

Blood glucose should be measured before anesthetic induction in neonates and very young pediatric patients, and glucose-containing maintenance fluids should be considered for procedures of any duration. Hypoglycemia in a pediatric patient under anesthesia can present as bradycardia, hypotension, or prolonged recovery, and it is easily overlooked if not specifically sought. Similarly, the high surface area to volume ratio of pediatric patients makes hypothermia a near-universal risk, and active warming measures must begin before induction instead of after core temperature has already fallen.

Monitoring and Equipment Considerations

Monitoring standards for pediatric patients should match or exceed those applied to adults, with the caveat that equipment must be sized appropriately. Pulse oximetry, capnography, electrocardiography, oscillometric or Doppler blood pressure, and temperature monitoring should be continuous throughout the anesthetic period, with values recorded at intervals no longer than five minutes. The AAHA anesthesia and monitoring guidelines for dogs and cats provide consensus recommendations on monitoring parameters and frequency that apply directly to pediatric patients.

The most common monitoring failures in pediatric anesthesia are not equipment malfunctions but failures of vigilance. A small patient can decompensate rapidly, and the interval between a normal reading and a critical event can be measured in seconds instead of minutes. Capnography is particularly valuable in pediatric patients because it detects hypoventilation and airway obstruction earlier than pulse oximetry alone. Blood pressure measurement requires an appropriately sized cuff, with the cuff width approximately 40 percent of the limb circumference, and Doppler methods are often more reliable than oscillometric devices in very small patients. Temperature monitoring should be continuous, and every anesthetic record for a pediatric patient should include a temperature trend line that demonstrates active management of thermal stability.

Preanesthetic Assessment and Risk Stratification

The pediatric preanesthetic evaluation begins with a targeted history that includes birth history, vaccination status, prior anesthetic exposures, and current body weight. Body weight is the single most useful objective measure of physiologic maturity in puppies and kittens, and it should be recorded to the nearest gram. A weight that is static or declining over consecutive days signals inadequate nutrition, dehydration, or systemic illness, any of which should delay elective procedures.

Physical examination in the pediatric patient must include auscultation for murmurs, arrhythmias, and bronchial sounds, because congenital cardiac and respiratory anomalies are more prevalent in this population. Patent ductus arteriosus, ventricular septal defects, and brachycephalic airway syndrome are common enough in young purebred dogs that their absence should be confirmed instead of assumed. The AAHA anesthesia and monitoring guidelines recommend that every patient have a documented American Society of Anesthesiologists physical status classification, and this applies equally to pediatric patients.

Preanesthetic blood work is indicated for any procedure expected to last longer than 30 minutes, for patients with suspected systemic disease, and for all patients undergoing ovariohysterectomy or orchiectomy. A minimum database includes packed cell volume, total protein, blood glucose, and a visual assessment of mucous membrane color. Blood glucose measurement is mandatory in patients under 12 weeks of age because hepatic glycogen reserves are limited and fasting hypoglycemia can develop rapidly.

Risk stratification should incorporate the procedure type, the patient's age and weight, and the presence of comorbidities. A patient with a heart murmur that is grade III or louder, or any murmur accompanied by syncope or exercise intolerance, warrants echocardiography before anesthesia. Patients with suspected congenital portosystemic shunts, indicated by poor growth, ptyalism, or neurologic signs, require bile acid testing before any anesthetic event. The decision to proceed with surgery in a pediatric patient with a confirmed congenital anomaly should involve a discussion with the owner about perioperative mortality risk and long-term prognosis.

Equipment Selection and Airway Management

Pediatric patients require equipment sized to their anatomy, and this is not a matter of simply using the smallest available adult tools. Endotracheal tube sizes range from 2.0 to 4.5 mm internal diameter in puppies and kittens, and the clinician should have at least two tubes of the predicted size and one size smaller available before induction. A cuffed tube is acceptable when the cuff is inflated only to the point of a leak at 15 to 20 cm H2O airway pressure, but many anesthetists prefer uncuffed tubes in patients under 2 kg to reduce the risk of tracheal mucosal ischemia.

The breathing circuit choice depends on patient weight. A non-rebreathing circuit, such as a Bain or Jackson-Rees modification of the Ayre's T-piece, is required for patients under 5 kg because rebreathing circuits impose excessive resistance and dead space. The fresh gas flow rate for a non-rebreathing circuit must be set high enough to prevent rebreathing, typically two to three times the patient's minute ventilation. The MSD Veterinary Manual provides species-specific guidance on circuit selection and ventilator settings that should be consulted before anesthetizing any patient under 3 kg.

Ventilation should be assessed continuously. Spontaneous ventilation under anesthesia in a pediatric patient is often shallow and irregular, and apnea can develop without warning. Capnography is the most reliable indicator of ventilation adequacy, and an end-tidal carbon dioxide reading between 35 and 45 mm Hg indicates appropriate minute ventilation. A rising end-tidal carbon dioxide with stable respiratory rate suggests hypoventilation, while a falling reading may indicate hyperventilation, reduced cardiac output, or an equipment leak.

Induction and Maintenance Protocols

The induction technique should be selected based on the patient's temperament, fasting status, and cardiovascular reserve. Mask induction with sevoflurane or isoflurane remains practical for small kittens and puppies that are too fractious for intravenous catheter placement, but it prolongs the excitement phase and increases the risk of laryngospasm and breath-holding. Intravenous induction after placement of a 24 or 26 gauge catheter is preferred in patients that tolerate handling, because it allows rapid airway control and reduces total anesthetic exposure.

The choice of induction agent should account for the patient's hemodynamic status. Patients with congenital heart disease, particularly those with right-to-left shunts, are sensitive to the vasodilatory effects of propofol and may develop profound hypotension. In these patients, a dissociative-based protocol or a carefully titrated benzodiazepine-opioid combination may be more appropriate. The dexmedetomidine literature in pediatric cardiac patients documents that this agent can provide sedation and analgesia with minimal effects on pulmonary vascular resistance, making it a reasonable adjunct in selected patients, although bradycardia remains a recognized adverse effect.

Maintenance anesthesia is typically achieved with a volatile agent delivered in oxygen. The minimum alveolar concentration of volatile anesthetics is higher in neonates than in adults, but the clinical implication is not that higher vaporizer settings are required. Rather, the increased minimum alveolar concentration is offset by the greater sensitivity of pediatric patients to the cardiorespiratory depressant effects of these agents, and the vaporizer setting should be titrated to the lowest setting that maintains an adequate depth of anesthesia. A balanced protocol that includes an opioid, a local anesthetic block, and a low-dose volatile agent reduces the requirement for any single drug and improves hemodynamic stability.

Monitoring Parameters and Physiologic Targets

Monitoring in pediatric patients requires the same modalities used in adults, but the interpretation of the values differs. Heart rate is the most sensitive indicator of anesthetic depth and nociception in puppies and kittens. A heart rate that rises more than 20 percent above the baseline value in response to surgical stimulation indicates inadequate analgesia, and the response should be to deepen the plane or administer additional analgesic, not to increase the volatile agent concentration.

Blood pressure measurement is technically challenging in small patients because the cuff must be appropriately sized, with a cuff width of approximately 40 percent of the limb circumference. Oscillometric devices are often inaccurate in patients under 3 kg, and Doppler ultrasound is the preferred method for systolic pressure measurement in this population. Mean arterial pressure should be maintained above 60 mm Hg, and systolic pressure above 80 mm Hg. Hypotension in a pediatric patient is most often caused by excessive anesthetic depth, hemorrhage, or hypovolemia, and the response should be a systematic assessment of each of these factors.

Pulse oximetry readings below 95 percent warrant immediate investigation. The differential diagnosis includes hypoventilation, endotracheal tube obstruction or malposition, pneumothorax, and reduced cardiac output. The probe should be placed on the tongue, a toe web, or the pinna, and the reading should be correlated with the capnograph and the heart rate.

Temperature Management and Fluid Therapy

Hypothermia is the most common preventable complication in pediatric anesthesia. The ratio of body surface area to body mass is high in puppies and kittens, and the thermoregulatory center is immature, so core temperature can drop by 1 to 2 C within the first 15 minutes of anesthesia. Active warming must begin before induction and continue through recovery. Forced-air warming blankets, circulating water blankets, and warmed intravenous fluids are all appropriate, and the patient's temperature should be recorded every 5 minutes during the procedure.

Fluid therapy in pediatric patients must account for the small circulating volume. A 1 kg kitten has a blood volume of approximately 60 to 80 mL, and a loss of 10 mL represents a significant fraction of that volume. Maintenance fluid rates are higher on a per-kilogram basis than in adults, but the total volume administered must be calculated carefully and reassessed at least every 15 minutes. A balanced isotonic crystalloid at a rate of 5 to 10 mL/kg per hour is a reasonable starting point for most procedures, with adjustments based on blood loss, duration of fasting, and cardiovascular status. Blood glucose should be rechecked at the end of the procedure, and dextrose supplementation should be considered if the value is below 80 mg/dL.

Recovery and Discharge Criteria

Recovery from anesthesia in pediatric patients is a high-risk period. Hypothermia, hypoglycemia, and respiratory depression can all emerge as the volatile agent is withdrawn, and the patient should not be left unattended until it is sternal and responsive. Active warming should continue through recovery, and the patient's temperature should be above 37 C (98.6 F) before it is returned to its dam or littermates.

Discharge criteria should include a stable temperature, a normal blood glucose, the ability to maintain sternal recumbency, and the absence of pain as assessed by a validated scoring system. The WSAVA Global Pain Council guidelines emphasize that pain assessment should be repeated at regular intervals and that analgesic plans should be adjusted based on the score. Owners should receive written instructions that include the expected duration of recovery, the signs that warrant re-examination, and the schedule for analgesic administration. The AVMA practice resources provide additional guidance on perioperative care standards that can be adapted to the pediatric patient.

Recognized Complications and Early Detection

The most consequential complications in pediatric anesthesia are airway obstruction, hypothermia, hypoglycemia, bradycardia, and hypotension. Each has a characteriztic temporal pattern and a discriminating monitoring finding.

Airway obstruction in brachycephalic puppies and kittens often presents as progressive inspiratory effort with a declining capnogram waveform despite unchanged endotracheal tube position. The capnogram loses its rectangular shape, developing a sloping plateau, before SpO₂ falls. Early detection depends on continuous waveform capnography instead of intermittent auscultation. Laryngospasm in kittens presents as sudden inspiratory stridor with paradoxical chest wall motion and a flat capnogram despite apparent ventilatory effort.

Hypothermia develops rapidly because the surface area to mass ratio is high and thermoregulatory reserves are minimal. Core temperature below 36°C produces progressive bradycardia, prolonged drug metabolism, and impaired coagulation. Continuous esophageal or rectal temperature monitoring with active warming from induction through recovery is the standard of care. The AAHA anesthesia and monitoring guidelines emphasize temperature as a core monitoring parameter in every anesthetic period.

Hypoglycemia is a particular risk in neonates and toy breeds with limited glycogen stores. Signs are nonspecific and include lethargy, tremors, and bradycardia that does not respond to lightening of anesthetic depth. Preanesthetic blood glucose measurement and intraoperative rechecking at 30 minute intervals in patients under 12 weeks of age are prudent. The MSD Veterinary Manual identifies hypoglycemia as a leading metabolic complication in pediatric small animal patients.

Bradycardia in pediatric patients is often the first sign of hypoxemia, hypotension, or excessive anesthetic depth. Unlike adults, cardiac output in neonates is heart rate dependent because stroke volume is relatively fixed. A heart rate below 100 beats per minute in a puppy or kitten warrants immediate evaluation of oxygenation, ventilation, and anesthetic delivery. Hypotension is detected by oscillometric or Doppler blood pressure measurement, with Doppler systolic values below 80 mmHg prompting intervention.

Common Errors and Corrective Actions

The most frequent error is overestimating the required anesthetic dose. Pediatric patients have higher volume of distribution and reduced protein binding for many drugs, but their metabolic capacity is immature. The result is a narrow therapeutic window where standard weight-based doses produce prolonged recovery or cardiovascular depression. Diluting drugs to standard concentrations and calculating volumes carefully reduces dosing errors.

A second common error is delaying airway securement. Young patients desaturate rapidly because their functional residual capacity is small relative to oxygen consumption. Preoxygenation, rapid induction, and prompt endotracheal intubation are mandatory. The AAHA anesthesia and monitoring guidelines recommend that anesthetic circuits and airway equipment be selected and verified before induction begins.

A third error is inadequate analgesic planning. Pediatric patients feel pain and mount stress responses that complicate recovery. The WSAVA Global Pain Council guidelines support multimodal analgesia with careful dose adjustment for age and body weight. Regional techniques reduce systemic drug requirements and should be considered whenever the procedure permits.

A fourth error is premature discharge. Recovery in pediatric patients is prolonged relative to adults because drug clearance is slower and thermoregulation remains fragile. Discharge criteria should include stable temperature, normal mentation, and demonstrated ability to maintain airway patency.

Limitations of Current Evidence

The evidence base for anesthetic neurotoxicity in pediatric patients is drawn largely from animal models and human retrospective studies. The systematic review from the American Pediatric Surgical Association found that a single exposure to general anesthesia does not appear to produce measurable neurodevelopmental deficits in children, but the authors acknowledge that longer or repeated exposures carry unresolved risk. In vitro work using human neurons shows that ketamine produces dose and time dependent mitochondrial injury, but the translational relevance to clinical anesthesia remains uncertain. The FDA summary of anesthetic use in neonates and young children describes similar concerns and calls for continued research instead of definitive conclusions.

Expert opinion differs on several practical points. Some clinicians advocate deferring elective procedures beyond 12 weeks of age where feasible, while others consider the risk of delaying necessary surgery to be greater than the anesthetic risk. There is no consensus on a maximum safe duration of anesthesia in young patients. The dexmedetomidine review in pediatric congenital heart disease illustrates a broader theme: alpha-2 agonists are used widely in pediatric patients despite limited prospective safety data, and individual hemodynamic responses vary considerably.

Referral and Escalation Criteria

Referral to a specialist anesthesiologist or criticalist is warranted when a patient has congenital cardiac disease, known airway abnormalities, or a history of anesthetic complications. Patients requiring mechanical ventilation beyond the immediate postoperative period, those with refractory hypotension despite fluid and inotrope support, and those with persistent hypothermia despite active warming should be transferred to a facility with continuous monitoring and overnight care.

Laboratory involvement is indicated when preoperative screening reveals unexplained hypoglycemia, electrolyte disturbances, or evidence of hepatic or renal immaturity. Serial blood gas analysis during prolonged procedures helps detect the metabolic acidosis that accompanies hypothermia and poor perfusion.

Regulatory reporting is rarely required in small animal practice, but adverse drug reactions and unexpected deaths should be documented in the medical record and reported to the relevant pharmacovigilance program where one exists. The AVMA practice resources provide guidance on adverse event reporting obligations in the United States.

Troubleshooting Guide

Frequently Asked Questions

How should I adjust my anesthetic plan when advanced monitoring equipment is unavailable?

When pulse oximetry, capnography, or blood pressure monitoring is not available, increase the frequency of direct physiologic assessment. Palpate peripheral pulses and assess mucous membrane color and capillary refill time every five minutes. Monitor heart rate and respiratory rate continuously by auscultation or Doppler ultrasound if available. Electrocardiography alone does not confirm perfusion or ventilation. The AAHA anesthesia and monitoring guidelines recommend that the same parameters be assessed regardless of equipment availability, with manual checks substituting for electronic surveillance. Extend the monitoring interval only when the patient is stable and the procedure is minimally stimulating. If the patient deteriorates, revert to continuous manual assessment and consider postponing elective procedures until appropriate monitoring can be sourced.

What are the practical limits of pediatric anesthesia in a general practice setting?

General practice can safely anesthetize many pediatric patients when the caseload allows dedicated personnel and appropriate equipment. Limits arise when the practice lacks pediatric-sized endotracheal tubes, intravenous catheters, or warming devices, or when staff cannot dedicate one person solely to monitoring. Practices without capnography or blood pressure measurement should restrict pediatric anesthesia to short, low-risk procedures. Referral is appropriate for patients with congenital cardiac disease, severe systemic illness, or anticipated difficult airways. The MSD Veterinary Manual advises that anesthetic risk in young animals is highest in the first weeks of life and declines with age, so procedures should be deferred until the patient reaches an appropriate size and developmental stage whenever clinically feasible.

How do I communicate anesthetic risk to an owner of a very young puppy or kitten?

Explain that young animals have smaller body reserves, higher surface area to volume ratios, and immature drug metabolism compared with adults. State the specific risks for the planned procedure, including hypothermia, hypoglycemia, and hypotension. Describe the monitoring that will be used and the steps taken to mitigate each risk. The WSAVA pain management guidance emphasizes that adequate analgesia is part of safe anesthetic care, so reassure owners that pain relief will not be withheld out of fear of complications. Be honest about the higher risk profile compared with an adult patient, but distinguish between manageable risk and unacceptable risk. Offer a clear plan for how complications would be recognized and treated, and document the discussion in the medical record.

What documentation is specifically important for pediatric anesthetic cases?

Record body weight to the nearest gram, body temperature before and after the procedure, and the time of each intervention. Document fasting start and end times, preanesthetic medication, induction and maintenance drug totals, and all monitoring values at intervals no longer than five minutes. Note any deviations from the planned protocol and the reason for each change. The AAHA anesthesia guidelines recommend recording recovery milestones, including time to sternal recumbency, time to standing, and return of normal feeding behavior. For pediatric patients, record the time of first urination and defecation after recovery, as delayed elimination may indicate hypothermia or inadequate perfusion. Include a clear statement of discharge criteria met and instructions given to the owner.

How does the approach differ for pediatric exotic or non-traditional small mammals?

Pediatric rabbits, ferrets, and rodents present additional constraints because of their small size, high metabolic rate, and susceptibility to stress. Fasting is generally unnecessary or should be very short, as these species cannot vomit and prolonged fasting risks hypoglycemia. Preanesthetic handling must minimize stress, since catecholamine release can cause arrhythmias or ileus. The WSAVA pain guidelines note that analgesic requirements vary substantially across species, and extrapolation from dogs and cats is unreliable. Equipment selection is more limited, and airway management may require supraglottic devices or mask anesthesia instead of intubation. Recovery should occur in a warm, quiet, species-appropriate enclosure. Consultation with a colleague experienced in exotic species is advisable before anesthetizing these patients in a practice without that caseload.

What should I do when an owner requests a procedure be performed without any anesthetic drugs?

Explain that restraint alone causes stress, pain, and a marked stress response that can be more physiologically harmful than a carefully administered anesthetic. The AAHA anesthesia guidelines state that adequate sedation or anesthesia is required for any procedure that would cause pain or require immobility. For minor procedures such as nail trims, gentle manual restraint with a single assistant may be acceptable, but for any procedure involving tissue penetration, fracture manipulation, or significant manipulation, anesthesia is required. Offer alternatives such as sedation combined with local anesthesia for very short procedures. If the owner continues to refuse, decline to perform the procedure and refer them to another practice, documenting the refusal and the risks of proceeding without anesthesia.

Related Clinical & Scientific Guides

• Anesthetic Machine Leak Testing and Pressure Checks: A Step-by-Step Protocol
• Anesthetic Depth Assessment: Reflexes, Eye Position, and Ventilation
• Anesthesia for Patients with Obesity: Challenges and Solutions

References and Further Reading

• The effects of early anesthesia on neurodevelopment: A systematic review.. 2021.
• Use of anesthetic agents in neonates and young children.. 2007.
• Dexmedetomidine: applications for the pediatric patient with congenital heart disease.. 2011.
• Pediatric facial fractures from dog bites.. 2013.
• Ketamine induces toxicity in human neurons differentiated from embryonic stem cells via mitochondrial apoptosis pathway.. 2012.
• Spinal anesthesia with an indwelling catheter reduces the stress response in pediatric open heart surgery.. 2005.
• AAHA Anesthesia and Monitoring Guidelines for Dogs and Cats. AAHA.
• WSAVA Global Pain Council Guidelines. WSAVA.
• MSD Veterinary Manual, Professional Edition. MSD Veterinary Manual.

Related Articles

• Rabbit Anesthesia and Analgesia: Safe Protocols and Drug Considerations
• Anesthesia for Patients with Trauma: Emergency Considerations
• Anesthesia for Patients with Cancer: Paraneoplastic Syndromes
• Anesthesia for Patients with Sepsis: Hemodynamic Support
• Anesthesia for Patients with Ear Hematoma: Surgical Repair

This article is educational professional reference material for veterinary audiences. It is not a substitute for veterinary diagnosis, individual clinical judgment, current product labeling, or applicable regulatory requirements.